Related Experiment Video
Updated: Jul 9, 2026

06:21
Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform
Published on: May 10, 2024
MAPT S305I mutation: implications for argyrophilic grain disease
Gabor G Kovacs1, Alan Pittman, Tamas Revesz
1Institute of Neurology, Medical University of Vienna, Vienna, Austria.
Acta Neuropathologica
|December 11, 2007
Summary
A novel mutation in the tau gene (MAPT) caused familial frontotemporal dementia with a unique tau pathology resembling argyrophilic grain disease. This finding expands the known spectrum of MAPT-associated frontotemporal lobar degeneration.
Area of Science:
- Neuroscience
- Genetics
- Pathology
Background:
- Familial frontotemporal dementia (FTLD) linked to MAPT gene mutations typically presents with tau pathology.
- While many MAPT mutations mimic sporadic tauopathies, none have been documented to resemble argyrophilic grain disease (AgD).
Observation:
- A patient with a novel S305I MAPT mutation exhibited behavioral changes and cognitive decline.
- Neuropathological examination revealed a unique phenotype with tau-positive structures, including argyrophilic grains, but lacked classical markers like neurofibrillary tangles.
- The observed tau pathology closely mimicked that of sporadic AgD.
Findings:
- The S305I MAPT mutation significantly increased 4R-tau isoforms due to altered exon 10 splicing.
- The tau inclusions consisted solely of 4R-tau isoforms and straight filaments.
- Neuronal loss was prominent in the medial temporal cortex, hippocampus, and amygdala.
Implications:
- This case broadens the phenotypic spectrum of FTLD caused by MAPT mutations.
- The findings suggest that sporadic AgD may represent a distinct disease entity with shared neuropathological features.
- Understanding MAPT mutation effects on tau isoform ratios is crucial for diagnosing and characterizing FTLD subtypes.
Related Concept Videos
Translation
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Mutations
Overview
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Mismatch Repair
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
